Excelsior Medical Co., Ltd.

Taiwan Stock Exchange 4104.TW

Excelsior Medical Co., Ltd. Operating Income for the year ending December 31, 2023: USD 22.90 M

Excelsior Medical Co., Ltd. Operating Income is USD 22.90 M for the year ending December 31, 2023, a -19.31% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.

Excelsior Medical Co., Ltd. Operating Income for the year ending December 31, 2022 was USD 28.38 M, a 2.26% change year over year.
Excelsior Medical Co., Ltd. Operating Income for the year ending December 31, 2021 was USD 27.75 M, a -7.42% change year over year.
Excelsior Medical Co., Ltd. Operating Income for the year ending December 31, 2020 was USD 29.97 M, a 15.73% change year over year.
Excelsior Medical Co., Ltd. Operating Income for the year ending December 31, 2019 was USD 25.90 M, a 75.91% change year over year.

Key data

Date	Operating Income	EBIT	EBITDA	Net Income

Taiwan Stock Exchange: 4104.TW

Excelsior Medical Co., Ltd.

CEO	Mr. Ming-Cheng Chang
IPO Date	Dec. 28, 2007
Location	Taiwan
Headquarters	No. 880, Zhongzheng Road
Employees	774
Sector	Health Care
Industries Medical Instruments Pharmaceuticals

Description

Excelsior Medical Co., Ltd. distributes medical related systems in Taiwan, China, Japan, Korea, Malaysia, and the Philippines. The company offers equipment for hemodialysis, regular drug used in the medical institution, surgical equipment, and medical assistant electronics; and cosmetic equipment. It also provides medical administration services for single department. The company was founded in 1988 and is based in New Taipei City, Taiwan.

Key trends

Past 5 years